Targeting dynorphin/kappa opioid receptor systems to treat alcohol abuse and dependence
Open accessThe DOI matches its Crossref record; 35 of the 35 references it cites were found in a registry or an index.
Abstract
This review represents the focus of a symposium that was presented at the “Alcoholism and Stress: A Framework for Future Treatment Strategies” conference in Volterra, Italy on May 3–6, 2011 and organized / chaired by Dr. Brendan M. Walker. The primary goal of the symposium was to evaluate and disseminate contemporary findings regarding the emerging role of kappa-opioid receptors (KORs) and their endogenous ligands dynorphins (DYNs) in the regulation of escalated alcohol consumption, negative affect and cognitive dysfunction associated with alcohol dependence, as well as DYN / KOR mediation of the effects of chronic stress on alcohol reward and seeking behaviors. Dr. Glenn Valdez described a role for KORs in the anxiogenic effects of alcohol withdrawal. Dr. Jay McLaughlin focused on the role of KORs in repeated stress-induced potentiation of alcohol reward and increased alcohol consumption. Dr. Brendan Walker presented data characterizing the effects of KOR antagonism within the extended amygdala on withdrawal-induced escalation of alcohol self-administration in dependent animals. Dr. Georgy Bakalkin concluded with data indicative of altered DYNs and KORs in the prefrontal cortex of alcohol dependent humans that could underlie diminished cognitive performance. Collectively, the data presented within this symposium identified the multifaceted contribution of KORs to the characteristics of acute and chronic alcohol-induced behavioral dysregulation and provided a foundation for the development of pharmacotherapeutic strategies to treat certain aspects of alcohol use disorders.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Validation of open:closed arm entries in an elevated plus-maze as a measure of anxiety in the rat
Pellow, S., Chopin, P., File, S. E., & Briley, M. (1985) · Journal of Neuroscience Methods · doi:10.1016/0165-0270(85)90031-7 · Cited by 5,822
Actual causes of death in the United States
McGinnis, J. M. (1993) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1993.03510180077038 · Cited by 5,480
Koob, G. F., & Volkow, N. D. (2010) · Neuropsychopharmacology · doi:10.1038/npp.2009.110 · Cited by 5,340
Actual Causes of Death in the United States, 2000
Mokdad, A. H. (2004) · JAMA · doi:10.1001/jama.291.10.1238 · Cited by 5,211
Regier, D. A. (1990) · JAMA · doi:10.1001/jama.1990.03450190043026 · Cited by 3,962
Drug Addiction, Dysregulation of Reward, and Allostasis
Koob, G. (2001) · Neuropsychopharmacology · doi:10.1016/s0893-133x(00)00195-0 · Cited by 2,953
The mesolimbic dopamine reward circuit in depression
Nestler, E. J., & Carlezon, W. A. (2006) · Biological Psychiatry · doi:10.1016/j.biopsych.2005.09.018 · Cited by 2,059 · cited 2×
“Chronic alcohol-induced KORmediated attenuation of dopaminergic function is not inconsequential, as deficiencies in dopaminergic transmission in limbic areas have been posited to be the neurobiological basis of depression (Nestler & Carlezon, 2006).”
Naltrexone in the Treatment of Alcohol Dependence
Volpicelli, J. R. (1992) · Archives of General Psychiatry · doi:10.1001/archpsyc.1992.01820110040006 · Cited by 1,828
An opponent-process theory of motivation. I. Temporal dynamics of affect
Solomon, R. L., & Corbit, J. D. (1974) · Psychological Review · doi:10.1037/h0036128 · Cited by 1,704 · cited 2×
“…in operant self-administration From a theoretical perspective, one approach to the analysis of behaviors and underlying neuroadaptations associated with chronic alcohol exposure would be to apply the conceptual framework of the OpponenteProcess Theory of Motivation (Solomon & Corbit, 1974).”
The reinstatement model of drug relapse: history, methodology and major findings
Shaham, Y., Shalev, U., Lu, L., de Wit, H., & Stewart, J. (2003) · Psychopharmacology · doi:10.1007/s00213-002-1224-x · Cited by 1,615
Tzschentke, T. M. (2007) · Addiction Biology · doi:10.1111/j.1369-1600.2007.00070.x · Cited by 1,336
Alheid, G. F., & Heimer, L. (1988) · Neuroscience · doi:10.1016/0306-4522(88)90217-5 · Cited by 1,217
Dopamine and drug addiction: the nucleus accumbens shell connection
Di Chiara, G., Bassareo, V., Fenu, S., De Luca, M. A., Spina, L., Cadoni, C., Acquas, E., Carboni, E., Valentini, V., & Lecca, D. (2004) · Neuropharmacology · doi:10.1016/j.neuropharm.2004.06.032 · Cited by 935
Di Chiara, G., & Imperato, A. (1988) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)24578-5 · Cited by 916
Regulation of cocaine reward by CREB
Carlezon, W. A., Thome, J., Olson, V. G., Lane-Ladd, S. B., Brodkin, E. S., Hiroi, N., Duman, R. S., Neve, R. L., & Nestler, E. J. (1998) · Science · doi:10.1126/science.282.5397.2272 · Cited by 767
Impulsivity, frontal lobes and risk for addiction
Crews, F. T., & Boettiger, C. A. (2009) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2009.04.018 · Cited by 679 · cited 1×
“…Drimmer, et al., 2010; Walker, et al., 2011) or dysregulated cognitive processing associated with decision-making and behavioral control (Boettiger, Kelley, Mitchell, D’Esposito, & Fields, 2009; Crews & Boettiger, 2009; Love, Stohler, & Zubieta, 2009) that are characteristic of alcohol dependence.”
Comorbidity between DSM-IV alcohol use disorders and major depression: results of a national survey
Grant, B. F., & Harford, T. C. (1995) · Drug and Alcohol Dependence · doi:10.1016/0376-8716(95)01160-4 · Cited by 637
Pliakas, A. M., Carlson, R. R., Neve, R. L., Konradi, C., Nestler, E. J., & Carlezon, W. A. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-18-07397.2001 · Cited by 509 · cited 2×
“…2005; Todtenkopf, Marcus, Portoghese, & Carlezon, 2004), the anti-depressant properties of KOR antagonists (Carr et al., 2010; Mague et al., 2003; Pliakas et al., 2001) and involvement of KORs with the dysphoria produced by stress (Land et al., 2008; McLaughlin, Marton-Popovici, & Chavkin, 2003).”
A key role for corticotropin-releasing factor in alcohol dependence
Heilig, M., & Koob, G. F. (2007) · Trends in Neurosciences · doi:10.1016/j.tins.2007.06.006 · Cited by 503 · cited 1×
“However, there are currently no pharmacological treatments for the negative affective consequences of excessive alcohol use (Heilig & Koob, 2007), and antidepressant treatment has produced mixed results in reducing alcohol consumption in dependent individuals (Torrens, Fonseca, Mateu, & Farre,…”
Antidepressant-Like Effects of κ-Opioid Receptor Antagonists in the Forced Swim Test in Rats
Mague, S. D., Pliakas, A. M., Todtenkopf, M. S., Tomasiewicz, H. C., Zhang, Y., Stevens, W. C., Jones, R. M., Portoghese, P. S., & Carlezon, W. A. (2003) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.102.046433 · Cited by 485 · cited 2×
“…Duman, & Nestler, 2005; Todtenkopf, Marcus, Portoghese, & Carlezon, 2004), the anti-depressant properties of KOR antagonists (Carr et al., 2010; Mague et al., 2003; Pliakas et al., 2001) and involvement of KORs with the dysphoria produced by stress (Land et al., 2008; McLaughlin,…”
Changes in depression among abstinent alcoholics
Brown, S. A., & Schuckit, M. A. (1988) · Journal of Studies on Alcohol · doi:10.15288/jsa.1988.49.412 · Cited by 412 · cited 2×
“These symptoms of negative affect appear to be intensified depending on the presence of physiological signs of withdrawal (i.e., depending on the level of dependence) and can persist for extended periods after such withdrawal has dissipated (Brown & Schuckit, 1988).”
Rassnick, S., Heinrichs, S. C., Britton, K. T., & Koob, G. F. (1993) · Brain Research · doi:10.1016/0006-8993(93)91352-s · Cited by 407
Pharmacological evidence for a motivational role of κ-opioid systems in ethanol dependence
Walker, B. M., & Koob, G. F. (2008) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301438 · Cited by 392 · cited 8×
“…generally show no effect on non-dependent alcohol self-administration (Doyon, Howard, Shippenberg, & Gonzales, 2006; Logrip, Janak, & Ron, 2008; Walker, Drimmer, et al., 2010; Walker & Koob, 2008a; Williams &Woods, 1998; Walker, Zorrilla, & Koob, 2011), but see Mitchell, Liang, and Fields (2005).”
InfluentialSelf-citationValdez, G. R., Roberts, A. J., Chan, K., Davis, H., Brennan, M., Zorrilla, E. P., & Koob, G. F. (2002) · Alcoholism: Clinical and Experimental Research · doi:10.1111/j.1530-0277.2002.tb02448.x · Cited by 387 · cited 3×
“Rats chronically exposed to alcohol show decreased open arm exploration in the EPM, an indication of an anxiety-like state, when tested during withdrawal (Baldwin et al., 1991; Rasmussen, Mitton, Green, & Puchalski, 2001; Rassnick et al., 1993; Valdez et al., 2002; Valdez, Sabino, & Koob, 2004).”
Self-citationDynorphin and the pathophysiology of drug addiction
Shippenberg, T. S., Zapata, A., & Chefer, V. I. (2007) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2007.06.011 · Cited by 387 · cited 3×
“Within this context, KOR stimulation would be considered a punisher (i.e., the application of a negative stimulus), not a negative reinforcer as some have posited (Shippenberg et al., 2007).”
InfluentialDecreased brain reward produced by ethanol withdrawal
Schulteis, G., Markou, A., Cole, M., & Koob, G. F. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.13.5880 · Cited by 345
Intra-amygdala muscimol decreases operant ethanol self-administration in dependent rats
Roberts, A. J., Cole, M., & Koob, G. F. (1996) · Alcoholism: Clinical and Experimental Research · doi:10.1111/j.1530-0277.1996.tb01125.x · Cited by 340
Land, B. B., Bruchas, M. R., Schattauer, S., Giardino, W. J., Aita, M., Messinger, D., Hnasko, T. S., Palmiter, R. D., & Chavkin, C. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0910705106 · Cited by 301
Effects of κ-opioid receptor ligands on intracranial self-stimulation in rats
Todtenkopf, M. S., Marcus, J. F., Portoghese, P. S., & Carlezon, W. A. (2004) · Psychopharmacology · doi:10.1007/s00213-003-1680-y · Cited by 273 · cited 2×
“KOR system involvement with negative affective phenotypes (Carlezon et al., 2005; Todtenkopf et al., 2004) and the dysphoria”
Myrick, H., Anton, R. F., Li, X., Henderson, S., Randall, P. K., & Voronin, K. (2008) · Archives of General Psychiatry · doi:10.1001/archpsyc.65.4.466 · Cited by 258 · cited 2×
“In alcoholics, effects of naltrexone in response to alcohol cues, and during decision-making involve the orbitofrontal cortex (OFC; Koob & Volkow, 2010; Love et al., 2009; Myrick et al., 2008; O’Malley et al., 2002), while MOR binding in the dorsolateral prefrontal cortex (dl-PFC) is functionally related to alcohol cr…”
Shippenberg, T. S., Bals-Kubik, R., & Herz, A. (1987) · Brain Research · doi:10.1016/0006-8993(87)91667-2 · Cited by 166
Nealey, K. A., Smith, A. W., Davis, S. M., Smith, D. G., & Walker, B. M. (2011) · Neuropharmacology · doi:10.1016/j.neuropharm.2011.02.012 · Cited by 133 · cited 16×
“Consistent with previous research (Hyytia & Kiianmaa, 2001; June et al., 1998; June et al., 2004), intra-accumbensMOR/DOR antagonism (using a CTOP/ naltrindole cocktail) and nalmefene showed efficacy for reducing ethanol self-administration in non-dependent animals.”
InfluentialSelf-citationValdez, G. R., Sabino, V., & Koob, G. F. (2004) · Alcoholism: Clinical and Experimental Research · doi:10.1097/01.alc.0000128222.29875.40 · Cited by 131
Self-citationValdez, G. R., Platt, D. M., Rowlett, J. K., Rüedi-Bettschen, D., & Spealman, R. D. (2007) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.107.125484 · Cited by 99
Self-citationEthanol withdrawal enhances the prodynorphin system activity in the rat nucleus accumbens
Przewłocka, B., Turchan, J., Lasoń, W., & Przewłocki, R. (1997) · Neuroscience Letters · doi:10.1016/s0304-3940(97)00829-x · Cited by 80 · cited 1×
“Under conditions of chronic alcohol use (see Figure 1), the predicted response of the EOS would be attenuated MOR signaling and exacerbated DYN / KOR system activity, both of which are supported in the literature (Gianoulakis et al., 1996; Przewlocka et al., 1997; Turchan et al., 1999; Chen and Lawrence, 2000; Lindhol…”
Background
Cited by
The one-two punch of alcoholism: role of central amygdala dynorphins/kappa-opioid receptors
Kissler, J. L., Sirohi, S., Reis, D. J., Jansen, H. T., Quock, R. M., Smith, D. G., & Walker, B. M. (2014) · Biological Psychiatry · doi:10.1016/j.biopsych.2013.03.014 · Cited by 145
“Conversely, DYNs are the endogenous ligands for the κ-opioid receptor (KOR) (11) and produce dysphoria in humans, aversive behavior in animals and have been implicated in alcohol abuse and dependence(12), as well as the reinforcing and rewarding properties of other drugs of abuse such as nicotine and cocaine(13;14).”
Self-citationRole of the Dynorphin/Kappa Opioid Receptor System in the Motivational Effects of Ethanol
Anderson, R. I., & Becker, H. C. (2017) · Alcoholism: Clinical and Experimental Research · doi:10.1111/acer.13406 · Cited by 79
“…studies have shown that KOR antagonists are especially effective in reducing elevated ethanol intake in dependent animals with little or no effect on more modest ethanol consumption in non-dependent animals (Kissler and Walker, 2016; Rose et al., 2016; Walker and Koob, 2008; Walker et al., 2012).”
BackgroundTreatment-refractory substance use disorder: focus on alcohol, opioids, and cocaine
Soyka, M., & Mutschler, J. (2016) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2015.11.003 · Cited by 49
The subjective experience of acute, experimentally-induced Salvia divinorum inebriation
Addy, P. H., Garcia-Romeu, A., Metzger, M., & Wade, J. (2015) · Journal of Psychopharmacology · doi:10.1177/0269881115570081 · Cited by 36
Wei, G., Sirohi, S., & Walker, B. M. (2022) · Addiction Biology · doi:10.1111/adb.13138 · Cited by 15
Self-citation
Metadata
- Authors
- Walker, B. M., Valdez, G. R., McLaughlin, J. P., & Bakalkin, G.
- Venue
- Alcohol
- Publisher
- Elsevier BV
- Published
- 2012-06
- Volume
- 46
- Issue
- 4
- Pages
- 359-370
- ISSN
- 0741-8329 (ISSN-L)
- OpenAlex
- W2021066246
- Cited by
- 106
- References
- 35
- FWCI
- 5.29
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.